Innocan Pharma FY Results Show C$12.3m Net Loss Innocan reported FY2025 revenue of C$2.1m and a net loss of C$12.3m on Apr 2, 2026; cash C$6.8m implies roughly six months runway at estimated burn.

Innocan Pharma FY Results Show C$12.3m Net Loss: Innocan reported FY2025 revenue of C$2.1m and a net loss of C$12.3m on Apr 2, 2026; cash C$6.8m implies roughly six months runway at estimated burn. 👈 Read full analysis #InnocanPharma #Pharmaceuticals #FinancialResults #NetLoss #RevenueReport